Organicell Regenerative Medicine has filed a notice of an exempt offering of securities to raise $5,000,000.00 in New Equity and Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, Organicell Regenerative Medicine is raising $5,000,000.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Ian Bothwell played a key…